$1.63
-0.07[-4.12%]
At close: Apr 23
$1.63
0[0.00%]
PreMarket: 9:25AM EDT
Milestone Pharmaceuticals
(NASDAQ:MIST)Milestone Pharmaceuticals Stock (NASDAQ:MIST), Analyst Ratings, Price Targets, Predictions
Milestone Pharmaceuticals Inc has a consensus price target of $11.2, established from looking at the 13 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., Piper Sandler, and HC Wainwright & Co. on March 22, 2024, March 5, 2024, and February 26, 2024. With an average price target of $18.33 between HC Wainwright & Co., Piper Sandler, and HC Wainwright & Co., there's an implied 978.43% upside for Milestone Pharmaceuticals Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Piper Sandler
TD Cowen
Jefferies
Oppenheimer
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Milestone Pharmaceuticals
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/22/2024 | MIST | Buy Now | Milestone Pharmaceuticals | $1.70 | 1370.59% | HC Wainwright & Co. | Patrick Trucchio | → $25 | Reiterates | Buy → Buy | Get Alert |
| 03/05/2024 | MIST | Buy Now | Milestone Pharmaceuticals | $1.70 | 194.12% | Piper Sandler | Edward Tenthoff | $6 → $5 | Maintains | Overweight | Get Alert |
| 02/26/2024 | MIST | Buy Now | Milestone Pharmaceuticals | $1.70 | 1370.59% | HC Wainwright & Co. | Patrick Trucchio | → $25 | Reiterates | Buy → Buy | Get Alert |
| 12/27/2023 | MIST | Buy Now | Milestone Pharmaceuticals | $1.70 | 429.41% | TD Cowen | — | $17 → $9 | Maintains | Outperform | Get Alert |
| 08/14/2023 | MIST | Buy Now | Milestone Pharmaceuticals | $1.70 | 1370.59% | HC Wainwright & Co. | Patrick Trucchio | $25 → $25 | Reiterates | Buy → Buy | Get Alert |
| 06/20/2023 | MIST | Buy Now | Milestone Pharmaceuticals | $1.70 | 135.29% | Jefferies | Chris Howerton | $8 → $4 | Downgrade | Buy → Hold | Get Alert |
| 05/23/2023 | MIST | Buy Now | Milestone Pharmaceuticals | $1.70 | 1370.59% | HC Wainwright & Co. | Patrick Trucchio | → $25 | Reiterates | Buy → Buy | Get Alert |
| 05/15/2023 | MIST | Buy Now | Milestone Pharmaceuticals | $1.70 | 1370.59% | HC Wainwright & Co. | Patrick Trucchio | → $25 | Reiterates | Buy → Buy | Get Alert |
| 04/12/2023 | MIST | Buy Now | Milestone Pharmaceuticals | $1.70 | 664.71% | Oppenheimer | Leland Gershell | $16 → $13 | Maintains | Outperform | Get Alert |
| 03/30/2023 | MIST | Buy Now | Milestone Pharmaceuticals | $1.70 | 1370.59% | HC Wainwright & Co. | Patrick Trucchio | → $25 | Reiterates | → Buy | Get Alert |
| 03/09/2023 | MIST | Buy Now | Milestone Pharmaceuticals | $1.70 | 1370.59% | HC Wainwright & Co. | Patrick Trucchio | → $25 | Reiterates | → Buy | Get Alert |
| 11/14/2022 | MIST | Buy Now | Milestone Pharmaceuticals | $1.70 | 1370.59% | HC Wainwright & Co. | Patrick Trucchio | $20 → $25 | Maintains | Buy | Get Alert |
| 04/22/2022 | MIST | Buy Now | Milestone Pharmaceuticals | $1.70 | 488.24% | Piper Sandler | Edward Tenthoff | $8 → $10 | Upgrade | Neutral → Overweight | Get Alert |
FAQ
What is the target price for Milestone Pharmaceuticals (MIST)?
The latest price target for Milestone Pharmaceuticals (NASDAQ: MIST) was reported by HC Wainwright & Co. on March 22, 2024. The analyst firm set a price target for $25.00 expecting MIST to rise to within 12 months (a possible 1433.74% upside). 8 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Milestone Pharmaceuticals (MIST)?
The latest analyst rating for Milestone Pharmaceuticals (NASDAQ: MIST) was provided by HC Wainwright & Co., and Milestone Pharmaceuticals reiterated their buy rating.
When was the last upgrade for Milestone Pharmaceuticals (MIST)?
The last upgrade for Milestone Pharmaceuticals Inc happened on April 22, 2022 when Piper Sandler raised their price target to $10. Piper Sandler previously had a neutral for Milestone Pharmaceuticals Inc.
When was the last downgrade for Milestone Pharmaceuticals (MIST)?
The last downgrade for Milestone Pharmaceuticals Inc happened on June 20, 2023 when Jefferies changed their price target from $8 to $4 for Milestone Pharmaceuticals Inc.
When is the next analyst rating going to be posted or updated for Milestone Pharmaceuticals (MIST)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Milestone Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Milestone Pharmaceuticals was filed on March 22, 2024 so you should expect the next rating to be made available sometime around March 22, 2025.
Is the Analyst Rating Milestone Pharmaceuticals (MIST) correct?
While ratings are subjective and will change, the latest Milestone Pharmaceuticals (MIST) rating was a reiterated with a price target of $0.00 to $25.00. The current price Milestone Pharmaceuticals (MIST) is trading at is $1.63, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.